clinical practice guidelines for the assessment …
TRANSCRIPT
CLINICAL PRACTICE GUIDELINES FOR THE ASSESSMENT AND TREATMENT OF
CHILDREN WITH
COMPLEX ADHD
Matthew Hickling, CPNP-PC, MSN, BSN, RN
Developmental Pediatrics – Community Care Physicians, PC
DISCLOSURES
• I have no financial or professional disclosures
• There will be no discussion of non-FDA approved drugs.
LEARNING OBJECTIVES
• To review current co-morbidities in the diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)
• To provide a brief understanding of what treatment for complex ADHD entails
• Integrate knowledge of the diagnosisand management of ADHD in childrenwith comorbid disorders into theirprimary care patient managementplans
WHAT IS THE MOST COMMON COMORBIDITY WITH ADHD
Choice 1 – Anxiety Disorder
Choice 2 – Autism
Choice 3 – Oppositional Defiant Disorder
Choice 4 – Learning Disability
Choice 5 – Tic disorders
AAP AND SDBP
• American Academy of Pediatrics (AAP) =
• Population for diagnosis = All children ages 4-17 presenting to primary care (usually for the first time) with academic or behavioral problems and symptoms of inattention, hyperactivity, or impulsivity
• Society for Developmental and Behavioral Pediatrics (SDBP) guideline complements AAP and guides all professionals managing care of children and adolescents with complex ADHD
WHAT COMPLICATES THE EVALUATION AND TREATMENTS FOR A PATIENT TO BE CONSIDERED
“COMPLEX ADHD?”
Choice 1 – Presenting at an unusually early (<4
years) or late (>12years) age
Choice 2 – Having a coexisting condition
(medical, psychiatric, or developmental/learning)
Choice 3 – Moderate to severe impact of symptoms
on daily functioning and inadequate response to
treatment
Choice 4 – Primary care provider being uncertain
about the ADHD diagnosisChoice 5 – All the above
< 4 yearsPresentation at age > 12 years
Age
Complex ADHD
Developmental/learning issuesMedical diagnosesPsychiatric diagnoses
Co-occurring conditions
Moderate to SevereFunctional Impairment
Diagnostic uncertainty
Inadequate response to treatment
PRIMARY -• Focus on functional impairment to
improve long term outcome• Focus on psychosocial
treatment as the foundation for treatment of complex ADHD
Others include:
• Shared decision making and clinical judgement
• Interprofessional care
• Psychological Testing/Mental Health Assess
• Multimodal treatment
• Evidence Based Psychosocial Interventions
• Treatment for Coexisting Conditions
• Life Course Perspective.
SDBP CURRENT PRACTICE MODEL
CASE 1
• Male – 3 years / 6 months• Referral – rule out ASD
• Hx –
• 35 wks gestation / in utero cocaine exposure & several psychotropic medications during pregnancy.
• Unsure of alcohol or other illicit drugs
• Sx of drug withdrawal first few weeks after birth
• Dc’d directly into Foster Care. Living with Grandmother since 12 months of age.
• Hx (continued) –
• EI evaluation led to ST around 1yo. Transitioned to CPSE – placed in SE. Continues with ST and 12-month programming.
• On-going delays in language skills – speaking in 3–5-word sentences. Points for wants/needs.
• Enjoys playing with cars, puzzles, blocks. Not engaging in imaginative play and has avoided playing with others. Some improvement since starting school.
• Behaviorally – high activity level and increased impulsivity. Led to safety concerns. Difficulties in emotional regulation. Inflexible and difficulty with transition.
Complete medical & developmental history and physical examination
Evaluation of data from multiple settings, including any prior evaluations
Psychological and/or developmental assessment including assessment of symptom severity, functional impairment, and cognitive/developmental level
Verification of any prior diagnoses and assessment for coexisting conditions
SPECIALIST APPROACHComprehensive
Evaluation
ACADEMICS/ EARLY LEARNING
Academic underachievement/ Early LearningCo-occurring learning disabilities
Functional Impairment
SOCIAL INTERACTION Parent-child interaction problemsDifficult peer relationships & other social issues
SELF-CONCEPT Low self-esteem
ACTIVITIES Suboptimal community participationIncreased risk of accidents (injuries, driving)
CASE 1 (CONT)
Exam –
Delays in multiple domains of development
Free play – initially hesitant then cautiously engages with toys
Quiet and avoids eye contact
Demonstrates functional play – no complex imaginative play
Begins to run and climb and furniture
Nonverbal cognitive skills between 18-21 months
Drawing skills – 15 months
Initially – no speaking. Once comfortable – single words and short phrases. Mix of words and jargon.
Frustration when not understood
Evidence of diminished attention span, increased impulsivity, and difficulty with emotional regulation.
Some difficulty with transition
WHAT DO YOU THINK IS THE DIAGNOSIS FOR THIS CHILD?
Choice 1 – Anxiety
Choice 2 – ADHD
Choice 3 – Autism
Choice 4 – Disruptive and Oppositional Behavior
Choice 5 – Multiple Co-Morbidities
MANAGEMENT
• Behavioral interventions are the first line of treatment• Families should look for a therapist who
focuses on training parents – Behavioral Parent Training (BPT)
• Project TEACH Provider Database• School based interventions (daily report
cards, classroom token economy, 504/IEP, Functional Behavioral Analysis and Behavior Intervention Plans.
• Peer focused social skills (Behavioral Peer Intervention)
• Trauma focused interventions when indicated• When behavioral treatment is not available,
clinicians must weigh risks and benefits of starting medication vs. harm of delaying treatment
PRESCHOOL-AGED CHILDREN (3-6 YEARS)
Barbaresi WJ, Campbell L, Diekroger EA, et al. The Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder: Process of Care Algorithms. J Dev Behav Pediatr. 2020;41 Suppl 2S:S58-S74. doi:10.1097/DBP.0000000000000781
CASE 2
• Jacob is an active 7-year-old recently diagnosed with ADHD
• Referred to office for “ADHD and something more.”
• Attempted methylphenidate 10mg daily one month ago. Administered before 8am daily.
• Limited appetite during the day. No difficulty with insomnia.
• Mom notes impulsivity worse – getting in trouble in school for “meltdowns.”
• He has yelled, fought, and damaged classroom property.
• Mom states he will come into her room at night because he is worried there is a “bad man” in the house
• Meds stopped 2 days ago and there has been a decrease in anger.
CASE 2 (CONT.)
• We did a SCARED and re-did hisVanderbilt scale.
• Vanderbilt positive for H/I symptoms,
• SCARED positive for anxiety disorder, separation anxiety, and social anxiety disorder
• Confirmed his prenatal history was negative for maternal illness, maternal substance use and confirmed he had no perinatal difficulties.
• Development is normal
• Academic achievement has been good until this academic year
DIAGNOSTIC ASSESSMENT
• Determine that DSM-5 criteria have been met
• Document symptoms and impairment in more than 2 major settings
• Rule out any other alternative cause of symptoms/impairment
• Screen for comorbid conditions, including
• emotional/behavioral conditions (e.g., anxiety, depression, ODD, conduct disorder, substance use)
• developmental conditions (e.g., autism spectrum disorder, learning disorders, language disorders)
• physical conditions (e.g., tics, OSA)
ACADEMICS Academic underachievementCo-occurring learning disabilities
Functional Impairment
SOCIAL INTERACTION Parent-child interaction problemsDifficult peer relationships & other social issues
SELF-CONCEPT Low self-esteem
ACTIVITIES Suboptimal community participationIncreased risk of accidents (injuries, driving)
WHAT DO YOU THINK IS THE CO-MORBID DIAGNOSIS FOR THIS CHILD?
Choice 1 – Anxiety
Choice 2 – Autism
Choice 3 – Oppositional Defiant Disorder
ANXIETY
15% to 35% of kids with ADHD have a coexisting anxiety disorder.
Commonly present with somatic complaints- esp H/A and SA
Many end up with OCD behaviors
Crying, irritability and anger may be misunderstood as oppositionality or defiance
So, which one is causing more problems and more impairment?
Is anxiety improved and now less impairing than ADHD?
ADHD and Coexisting Anxiety Child with ADHD and Anxiety
• Begin Cognitive Behavioral Therapy (CBT)
• Monitor response
Continue CBT and consider modification (e.g., more parent
involvement, more in vivo exposures)
• Initiate 8 week trial of SSRI • Continue CBT• Monitor response
• Continue to adapt CBT• Consider medication change • Monitor and modify treatment
Is anxiety more impairing than ADHD?
To Behavioral/Educational Treatment of Complex
ADHD Algorithm
To Behavioral/Educational Treatment of Complex
ADHD Algorithm
To Behavioral/Educational Treatment of Complex
ADHD Algorithm
Is anxiety improved and now less impairing than ADHD?
Is anxiety improved and now less impairing than ADHD?
To Behavioral/Educational Treatment of Complex
ADHD Algorithm
NoYes
Yes
No
Yes
No
NoYes
Barbaresi WJ, Campbell L, Diekroger EA, et al. The Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder: Process of Care Algorithms. J Dev Behav Pediatr. 2020;41 Suppl 2S:S58-S74. doi:10.1097/DBP.0000000000000781
MANAGEMENT
• Consider what might be the Primary condition “driving the bus.”• Cognitive Behavioral Therapy
Re-evaluation: IF symptoms have improved – Continue with Behavioral/Educational treatment – CBT,
classroom, etc.IF symptoms have NOT improved –
- Continue CBT and consider modifications (increasing parental involvement)Re-evaluation:
IF symptoms have improved – Continue with Behavioral/Educational treatment – CBT, classroom, etc.
IF symptoms have NOT improved –- Initiate 8-week trial of SSRI- Continue CBT and consider modifications (increasing parental involvement)- Monitor response
COMMUNITY RESOURCES
County Mental Health Clinics
Non-for-Profit Organizations• Northern Rivers• BHSN• St. Catherine’s
School Counseling services
Private Therapists
Community Care Physicians, PC –
Integrated Behavioral Health Team
Project TEACH
PCP APPROACH
Refer to a specialist with appropriate training or expertise
Screen broadly for co-existing conditions and functional impairment
Consider who may benefit from a comprehensive assessment
ADVOCACY AND FUTURE RESEARCH
• The guideline highlights the need for advocacy to address the many systemic barriers to delivering optimal care for complex ADHD.
• These include: • Financial barriers • Inadequate expertise and recognizing complexity
• Limited number of subspecialists • Limited resources within the education system T
•Health care systems to defer financial and treatment responsibility
SUMMARY
• ADHD = Chronic Condition
• Start with psychoeducation
• Create a partnership with the family
• Develop a management plan with specific targeted goals
• If possible, include the teachers
• Plan for ongoing monitoring and anticipation of developmental changes & transitions
• Communication and coordination of care among all professionals involved in the treatment and management of children and adolescents with complex ADHD is of utmost importance.
REFERENCES
• Barbaresi WJ Campbell L, et al. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. J Dev Behav Pediatr 2020; 41:S1-S23
• Barbaresi WJ Campbell L, et al. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder: Process of Care Algorithms. J Dev Behav Pediatr. 2020b; 41: S1-17.
• Wolraich ML, Chan E, Froehlich T, et al.ADHD Diagnosis and Treatment Guidelines:A Historical Perspective. Pediatrics. 2019;144(4): e20191682
• Wolraich ML, Hagan JF, Allan C, et al. SUBCOMMITTEE ON CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE DISODER. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrcis. 2019; 144(4):e20192528
• SDBP Complex ADHD Guideline: Executive Summary. Zand D, Diekroger E, Koolwijk I, Noaln R, Augustyn M, Yang J, Buttross S, Mehlenbeck R, Froelich T.
• SDBP Complex ADHD Guideline: Talking Points for Clinicians and Health Care Providers. Ledesma M, Moore T, Nolan R, Lopez FA
• SPECIAL THANKS:
• Dawn Garzon Maaks – helped with advising on materials
• Dr. Ledesma and SDBP for information and helps with slides
• Dr. Anthony Malone, Dr. Chaudauri, Erin Larrabee, and Maude Kaye